BMJ · 1969 · 186 citations · 14 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyNeuropharmacologyCerebrovascular DiseaseStrokeDouble-blind Trials
A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.
14
EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOUR
P.R. Emmons, M J Harrison, A. J. Honour et al. · The Lancet · 1965 · 246 citations
Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the Rabbit
P.R. Emmons, M J Harrison, A. J. Honour et al. · Nature · 1965 · 136 citations
Controlled Double-blind Trial of "Persantin" in Treatment of Angina Pectoris
Tatum E. Foulds, Jill MacKinnon · BMJ · 1960 · 36 citations · Full text